Prime Medicine (PRME) Assets Average (2022 - 2026)

Prime Medicine has reported Assets Average for 5 years, with the latest figure at $318.7 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 1.88% year-over-year to $318.7 million; the trailing twelve-month figure through Mar 2026 stood at $318.7 million (up 1.88% YoY), and the FY2025 full-year result was $320.1 million, up 30.3% from the prior year.
• Assets Average for Q1 2026 stood at $318.7 million, down from $363.9 million in the prior quarter.
• The five-year high for Assets Average was $363.9 million in Q4 2025, with the low at $216.5 million in Q4 2023.
• Historically, Assets Average has averaged $298.7 million across 5 years, with a median of $301.2 million in 2023.
• The largest YoY upside for Assets Average was 45.57% in 2024 against a maximum downside of 25.4% in 2024.
• Prime Medicine's Assets Average stood at $287.8 million in 2022, then slipped by 24.77% to $216.5 million in 2023, then soared by 45.57% to $315.1 million in 2024, then grew by 15.46% to $363.9 million in 2025, then retreated by 12.41% to $318.7 million in 2026.
• The last three Assets Average figures came in at $318.7 million (Q1 2026), $363.9 million (Q4 2025), and $332.0 million (Q3 2025), per Business Quant data.